234 Marandi et al.
Calcd. for C34H37O6N2SP (632.71): C, 64.54; H, 5.89;
N, 4.43. Found: C, 64.69; H, 6.04; N, 4.51.
δ 12.70 (2NCH2CH3), 27.05 and 27.36 (2s, 2CMe3),
2
41.31 and 42.17 (2NCH2), 42.42 (d, JPC = 4.7 Hz,
Major isomer. 1H NMR (500.1 MHz, CDCl3):
δ 0.87–1.32 (12H, m, 2OCH2CH3 and 2NCH2CH3),
3.61 and 3.78 (4H, 2m, 2ABX3 system, 2OCH2CH3),
4.61 (4H, m, ABX3 system 2NCH2CH3), 5.29 (1H,
br, P CH CH), 5.66 (1H, br, P CH CH), 7.48–7.90
(15H, m, 3C6H5); 13C NMR (125.8 MHz, CDCl3): δ
12.72 (2NCH2CH3), 13.56 and 13.79 (2OCH2CH3),
P CH CH), 43.45 (d, 1 JPC = 42.9 Hz, P CH), 81.63
3
and 84.01 (2C, 2OCMe3), 88.36 (d, JPC = 11.9 Hz,
1
P C C C), 122.23 (d, JPC = 88.9 Hz, Cipso), 129.26
3
(d, JPC = 12.8 Hz, Cmeta), 133.43 (Cpara), 134.41 (d,
2 JPC = 9.6 Hz, Cortho), 160.99 (O C C C O), 165.52
and 172.76 (2 C O, ester), 175.75 (C S). 31P NMR
(202.4 MHz, CDCl3): δ 25.17 ((Ph)3P+ C).
2
1
41.60 and 41.66 (2NCH2), 42.58 (d, JPC = 4.5
Minor isomer. H NMR (500.1 MHz, CDCl3): δ
1
Hz, P CH CH), 43.38 (d, JPC = 43.3 Hz, P CH),
1.02 and 1.27 (18H, 2s, 2CMe3), 1.07–1.23 (6H, br,
2NCH2CH3), 4.18 (4H, br, 2NCH2CH3), 5.15 (1H, dd,
3
61.81 and 62.62 (2OCH2CH3), 88.52 (d, JPC = 12.0
1
3
Hz, P C C C), 121.32 (d, JPC = 88.3 Hz, Cipso),
3 JHH = 10.7 Hz, and JPH = 6.5 Hz, P CH CH),
3
4
3
2
129.50 (d, JPC = 12.9 Hz, Cmeta), 133.87 (d, JPC
=
5.76 (1H, dd, JHH = 10.7 Hz, and JPH = 15.7 Hz,
P CH CH), 7.43–7.85 (15H, m, 3C6H5);13C NMR
(125.8 MHz, CDCl3): δ 12.70 (2NCH2CH3), 27.14 and
27.74 (2s, 2CMe3), 41.63 and 41.71 (2NCH2), 42.47
(P CH CH), 42.84 (d, 1 JPC = 49.8 Hz, P CH), 80.63
2.6 Hz, Cpara), 134.35 (d, 2 JPC = 9.7 Hz, Cortho), 161.00
(O C C C O), 166.88 and 173.74 (2C O, ester),
176.05 (C S). 31P NMR (202.4 MHz, CDCl3): δ 24.28
((Ph)3P+ C).
Minor isomer. 1H NMR (500.1 MHz, CDCl3):
δ 0.87–1.32 (12H, m, 2OCH2CH3 and 2NCH2CH3),
3.61 and 3.78 (4H, 2m, 2ABX3 system, 2OCH2CH3),
4.21 (4H, m, ABX3 system, 2NCH2CH3), 5.07 (1H,
and 83.62 (2C, 2OCMe3), 88.57 (d, JPC = 2.1 Hz,
3
1
P C C C), 118.49 (d, JPC = 85.2 Hz, Cipso), 129.33
3
(d, JPC = 12.9 Hz, Cmeta), 133.43 (Cpara), 134.48 (d,
2 JPC = 9.6 Hz, Cortho), 160.79 (O C C C O), 165.09
(d, 2 JPC = 1.7 Hz, C O, ester), 171.82 (d, 3 JPC = 18.1
Hz, C O, ester), 175.45 (C S). 31P NMR (202.4 MHz,
CDCl3): δ 25.31 ((Ph)3P+ C).
3
3
dd, JHH = 11.0 Hz and JPH = 6.0 Hz, P CH CH),
3
3
5.90 (1H, dd, JHH = 11.0 Hz and JPH = 13.2 Hz,
P CH CH), 7.48–7.90 (15H, m, 3C6H5); 13C NMR
(125.8 MHz, CDCl3): δ 13.31 (2NCH2CH3), 14.05
and 14.19 (2OCH2CH3), 41.91 and 41.98 (2NCH2),
REFERENCES
42.49 (d, 2 JPC = 4.6 Hz, P CH CH), 42.66 (d, 1 JPC
=
50.3 Hz, P CH), 61.33 and 62.23 (2OCH2CH3), 88.67
[1] Katritzky, A. R. Chem Rev 2004, 104, 2125.
[2] Deiters, A.; Martin, S. F. Chem Rev 2004, 104, 2199.
[3] Ishida, M.; Minami, T.; Agawa, T. J Org Chem 1979,
44, 2067.
[4] Schell, P.; Richards, M. P.; Hanson, K.; Berk, S. C.;
Makara, G. M. J Comb Chem 2005, 7, 69.
[5] Maghsoodlou, M. T.; Hazeri, N.; Navvabian, H.;
Razmjoo, Z.; Marandi, G. J Chem Res (S) 2005, 401.
[6] Maghsoodlou, M. T.; Hazeri, N.; Habibi-Khorassani,
S. M.; Solimani, V.; Marandi, G.; Razmjoo, Z. J Chem
Res (S) 2008, 198.
[7] Hazeri, N.; Habibi-Khorassani, S. M.; Maghsoodlou,
M. T.; Marandi, G.; Nassiri, M.; Ghulame-Shahzadeh,
A. J Chem Res 2006, 215.
[8] Roth, H. J.; Kleemann, A. Pharmaceutical Chemistry;
Ellis Horwood: New York, 1988.
[9] Korolkovas, A. Essentials of Medicinal Chemistry,
2nd ed; Wiley-Interscience: New York, 1988.
[10] Cobridge, D. E. C. Phosphorus, An Outline of Chem-
istry, Biochemistry and Uses, 5th ed.; Elsevier:
Amsterdam, 1995.
[11] Engel, R. Synthesis of Carbon-Phosphorus Bond;
CRC Press: Boca Raton, FL, 1998.
[12] Cadogan, J. I. G. Organophosphorus Reagents in Or-
ganic Synthesis; Academic Press: New York, 1979.
[13] Kolodiazhnyi, O. I. Russ Chem 1997, 66, 225.
[14] Bestman, H. J.; Vostrowsky, O. Top Curr Chem 1983,
109, 85.
[15] Hassani, Z.; Islami, M. R.; Sheibani, H.; Kalantari,
M.; Saidi, K. Arkivoc 2006, i, 89.
3
1
(d, JPC = 2.3 Hz, P C C C), 118.02 (d, JPC
=
3
86.3 Hz, Cipso), 129.45 (d, JPC = 12.9 Hz, Cmeta),
4
2
133.87 (d, JPC = 2.6 Hz, Cpara), 134.28 (d, JPC 9.2
Hz, Cortho), 161.00 (O C C C O), 166.64 (d, 2 JPC
=
1.6 Hz, C O, ester), 172.60 (d, 3 JPC = 18.0 Hz, C O,
ester), 175.66 (C S). 31P NMR (202.4 MHz, CDCl3):
δ 23.94 ((Ph)3P+ C).
(2R∗,3R∗)-1,3-Diethyl-4,6-dioxo-2-thioxo-5-[2-
(triphenylphosphonio)-1,2-bis(tert-butoxy-
carbonyl)ethyl]tetrahydropyrimidin-5-ide (9c)
White Powder. Yield: 0.67 g, 97%. mp = 176–
178◦C; IR (KBr) (νmax, cm−1): 1724, 1732, and 1743
(C O). MS (m/z, %): 688 (M+, 4), 615 (M-OCMe3,
34), 587 (M CO2CMe3, 29), 490 (M C8H10N2O2S,
46), 262 (PPh3, 100), 183 (PPh2, 82), 108 (PPh, 36),
77 (Ph, 27). Anal. Calcd. for C38H45O6N2SP (688.81):
C, 66.26; H,6.58; N, 4.07. Found: C, 66.32; H, 6.61;
N, 3.95.
Major isomer. 1H NMR (500.1 MHz, CDCl3):
δ 0.94 and 0.99 (18H, 2s, 2CMe3), 1.07–1.23 (6H, br,
2NCH2CH3), 4.56 (4H, br, 2NCH2CH3), 4.85 (1H, dd,
3 JHH = 10.4 Hz,3 JPH = 6.2 HZ, P CH CH), 5.64 (1H,
dd, 3 JHH = 10.4 Hz, 2 JPH = 13.9 Hz, P CH CH), 7.43–
7.85 (15H, m, 3C6H5);13C NMR (125.8 MHz, CDCl3):
[16] Islami, M. R.; Mollazehi, F.; Badiei, A.; Sheibani, H.
Arkivoc 2006, xv, 25.
Heteroatom Chemistry DOI 10.1002/hc